Report overview
This report aims to provide a comprehensive presentation of the global market for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing. This report contains market size and forecasts of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in global, including the following market information:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AAV Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, by Type, 2022 (%)
AAV
Adenoviral
Lentiviral
Retroviral
Plasmid DNA
Other Vectors
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, by Application, 2022 (%)
Cancers
Inherited Disorders
Viral Infections
Others
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
bluebird bio
Novasep
Spark Therapeutics
Vigene Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, market overview.
Chapter 2: Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
